Is a complete INSM research report available?

No complete published report is available for Insmed Incorporated (INSM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Insmed Incorporated (INSM)

NASDAQ: INSM · USD

$97.3

+2.34 (+2.5%)· Recorded snapshot

Market cap	21.2B
Revenue (ttm)	1.1B
Net income (ttm)	-875.3M
EPS (ttm)	-$4.09
Shares out	218.4M
Volume	3,914,958
Beta	0.82

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.1B
Net income (ttm): -875.3M
EPS (ttm): -$4.09
Market cap: 21.2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Metric	Value
Amount currency	USD
CIK code	0001104506
Company name	Insmed Incorporated
Country	United States
Country code	US
CUSIP number	457669307
Earnings date	2026-10-29
Earnings time	bmo
Employees	1,664
Employees change	393
Employees growth	30.92%
Enterprise value	$20.8B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1988
Industry	Biotechnology
IPO date	2000-06-01
Is primary listing	Yes
Is SPAC	No
ISIN number	US4576693075
Last 10-K release date	2026-02-19
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2011-03-03
Last stock split type	Reverse
Market cap	$21.2B
Market cap category	Large-Cap
Next earnings date	2026-10-29
Options	Yes
Price	$97.30
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	INSM
U.S. state	New Jersey
Website	https://www.insmed.com

Metric

Value

Amount currency

USD

CIK code

0001104506

Company name

Insmed Incorporated

Country

United States

Country code

CUSIP number

457669307

Earnings date

2026-10-29

Earnings time

bmo

Employees

1,664

Employees change

393

Employees growth

30.92%

Enterprise value

$20.8B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1988

Industry

Biotechnology

IPO date

2000-06-01

Is primary listing

Yes

Is SPAC

ISIN number

US4576693075

Last 10-K release date

2026-02-19

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split date

2011-03-03

Last stock split type

Reverse

Market cap

$21.2B

Market cap category

Large-Cap

Next earnings date

2026-10-29

Options

Yes

Price

$97.30

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

INSM

U.S. state

New Jersey

Website

https://www.insmed.com

Metric	Value
Earnings yield	-4.2%
EV/Sales	18.21x
FCF / EV yield	-3.9%
FCF yield	-3.82%
Forward EV/Sales	8.52x
Forward P/S	8.69x
P/B ratio	27.36x
P/S ratio	18.58x
Price / tangible book value	38.53x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-4.2%

EV/Sales

18.21x

FCF / EV yield

-3.9%

FCF yield

-3.82%

Forward EV/Sales

8.52x

Forward P/S

8.69x

P/B ratio

27.36x

P/S ratio

18.58x

Price / tangible book value

38.53x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	-71.43%
EBITDA margin	-69.88%
Gross margin	83.46%
Operating margin	-71.43%
Pretax margin	-76.4%
Profit margin	-76.94%
Profit per employee	$-526,028
Revenue per employee	$683,675
ROA	-22.17%
ROA (5Y)	-25.98%
ROCE	-48.84%
ROE	-87.22%
ROIC	-29.14%
SBC / revenue	13.84%
Tax / revenue	0.55%

Metric

Value

EBIT margin

-71.43%

EBITDA margin

-69.88%

Gross margin

83.46%

Operating margin

-71.43%

Pretax margin

-76.4%

Profit margin

-76.94%

Profit per employee

$-526,028

Revenue per employee

$683,675

ROA

-22.17%

ROA (5Y)

-25.98%

ROCE

-48.84%

ROE

-87.22%

ROIC

-29.14%

SBC / revenue

13.84%

Tax / revenue

0.55%

Metric	Value
EPS growth quarters	2
EPS growth years	0
Gross profit growth	214.97%
Gross profit growth (Q)	351.57%
Gross profit growth 3Y	64.7%
Gross profit growth 5Y	49.19%
Net income growth quarters	2
Net income growth years	0
Revenue growth	185.76%
Revenue growth (Q)	296.11%
Revenue growth (QoQ)	39.06%
Revenue growth 3Y	61.62%
Revenue growth 5Y	46.15%
Revenue growth quarters	22
Revenue growth years	7

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

214.97%

Gross profit growth (Q)

351.57%

Gross profit growth 3Y

64.7%

Gross profit growth 5Y

49.19%

Net income growth quarters

Net income growth years

Revenue growth

185.76%

Revenue growth (Q)

296.11%

Revenue growth (QoQ)

39.06%

Revenue growth 3Y

61.62%

Revenue growth 5Y

46.15%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-28.7M
Depreciation and amortization	$17.7M
EBIT	$-812.6M
EBITDA	$-795M
EPS	$-4.09
FCF per share	$-3.70
Financing cash flow	$124M
Free cash flow	$-807.7M
Free cash flow minus SBC	$-965.1M
Gross profit	$949.4M
Income taxes	$6.2M
Investing cash flow	$-82.8M
Net borrowing	$-3.1M
Net cash flow	$-739.6M
Net income	$-875.3M
Operating cash flow minus SBC	$-936.4M
Operating income	$-812.6M
Revenue	$1.1B
Stock-based compensation	$157.5M

Metric

Value

Capital expenditures

$-28.7M

Depreciation and amortization

$17.7M

EBIT

$-812.6M

EBITDA

$-795M

EPS

$-4.09

FCF per share

$-3.70

Financing cash flow

$124M

Free cash flow

$-807.7M

Free cash flow minus SBC

$-965.1M

Gross profit

$949.4M

Income taxes

$6.2M

Investing cash flow

$-82.8M

Net borrowing

$-3.1M

Net cash flow

$-739.6M

Net income

$-875.3M

Operating cash flow minus SBC

$-936.4M

Operating income

$-812.6M

Revenue

$1.1B

Stock-based compensation

$157.5M

Metric	Value
Altman Z-Score	9.79
Book value per share	$3.47
Debt / equity	0.98
Goodwill	$136.1M
Interest coverage	-9.99
Long-term assets	$468.6M
Long-term liabilities	$906.3M
Net cash (debt)	$420.6M
Net cash / market cap	1.99%
Net cash growth	-62.37%
Net debt / equity	-0.56
Piotroski F-Score	3
Property, plant and equipment	$209.8M
Shareholders' equity	$757.5M
Tangible book value	$548.5M
Tangible book value per share	$2.51
Total assets	$2.1B
Total cash	$1.2B
Total debt	$739.7M
Total liabilities	$1.3B
WACC	8.78%

Metric

Value

Altman Z-Score

9.79

Book value per share

$3.47

Debt / equity

0.98

Goodwill

$136.1M

Interest coverage

-9.99

Long-term assets

$468.6M

Long-term liabilities

$906.3M

Net cash (debt)

$420.6M

Net cash / market cap

1.99%

Net cash growth

-62.37%

Net debt / equity

-0.56

Piotroski F-Score

Property, plant and equipment

$209.8M

Shareholders' equity

$757.5M

Tangible book value

$548.5M

Tangible book value per share

$2.51

Total assets

$2.1B

Total cash

$1.2B

Total debt

$739.7M

Total liabilities

$1.3B

WACC

8.78%

Metric	Value
Asset turnover	0.5
Current assets	$1.6B
Current liabilities	$438.7M
Current ratio	3.72
Inventory turnover	1.51
Net working capital	$44.7M
Quick ratio	3.14
Working capital	$1.2B
Working capital turnover	0.77

Metric

Value

Asset turnover

0.5

Current assets

$1.6B

Current liabilities

$438.7M

Current ratio

3.72

Inventory turnover

1.51

Net working capital

$44.7M

Quick ratio

3.14

Working capital

$1.2B

Working capital turnover

0.77

Metric	Value
Buyback yield / dilution	-18.73%
Dividend yield	0%
Shareholder yield	-18.73%

Metric

Value

Buyback yield / dilution

-18.73%

Dividend yield

Shareholder yield

-18.73%

Metric	Value
10Y price change	605.6%
10Y return CAGR	21.58%
10Y total return	605.6%
150-day SMA	$117.57
15Y price change	2,455%
15Y return CAGR	24.11%
15Y total return	2,455%
1D price change	2.46%
1M price change	-17.6%
1M total return	-17.6%
1W price change	1.48%
1W total return	1.48%
1Y price change	-40.81%
1Y return CAGR	-40.83%
1Y total return	-40.81%
20-day SMA	$98.95
200-day SMA	$125.93
20Y price change	652.64%
20Y return CAGR	10.62%
20Y total return	652.64%
3M price change	-7.29%
3M total return	-7.29%
3Y price change	306.58%
3Y return CAGR	59.59%
3Y total return	306.58%
50-day SMA	$113.30
50-day SMA vs 200-day SMA	50under200
52-week high	$212.75
52-week high date	2025-12-02
52-week low	$90.39
52-week low date	2026-06-10
5Y price change	267.77%
5Y return CAGR	29.76%
5Y total return	267.77%
6M price change	-28.6%
6M total return	-28.6%
All-time high	$212.75
All-time high date	2025-12-02
All-time low	$2.64
All-time low date	2011-11-25
Average true range (ATR)	$3.69
Average volume	3.2M
Beta (1Y)	0.98
Beta (2Y)	0.9
Beta (5Y)	0.82
Change from 52-week high	-54.27%
Change from 52-week low	7.65%
Change from all-time high	-54.36%
Change from all-time low	3,577.65%
Change from open	3.38%
Day's gap	-0.88%
Dollar volume	$380.9M
High price	$97.91
Low price	$94.12
Monthly RSI	46.77
Open price	$94.12
Position in 52-week range	83.91%
Premarket change	-0.42%
Premarket close	$94.96
Premarket price	$94.56
Premarket volume	2.2K
Previous close	$94.96
Price vs 150-day SMA	-17.42%
Price vs 20-day SMA	-1.88%
Price vs 200-day SMA	-22.9%
Price vs 50-day SMA	-14.3%
Relative volume	1.24
RSI	38.38
Sharpe ratio	-0.6
Sharpe ratio (3Y)	0.79
Sharpe ratio (5Y)	0.58
Sortino ratio	-0.8
Sortino ratio (3Y)	2.26
Sortino ratio (5Y)	1.41
Volume	3.9M
Weekly RSI	39.48
YTD price change	-44.21%
YTD total return	-44.21%

Metric

Value

10Y price change

605.6%

10Y return CAGR

21.58%

10Y total return

605.6%

150-day SMA

$117.57

15Y price change

2,455%

15Y return CAGR

24.11%

15Y total return

2,455%

1D price change

2.46%

1M price change

-17.6%

1M total return

-17.6%

1W price change

1.48%

1W total return

1.48%

1Y price change

-40.81%

1Y return CAGR

-40.83%

1Y total return

-40.81%

20-day SMA

$98.95

200-day SMA

$125.93

20Y price change

652.64%

20Y return CAGR

10.62%

20Y total return

652.64%

3M price change

-7.29%

3M total return

-7.29%

3Y price change

306.58%

3Y return CAGR

59.59%

3Y total return

306.58%

50-day SMA

$113.30

50-day SMA vs 200-day SMA

50under200

52-week high

$212.75

52-week high date

2025-12-02

52-week low

$90.39

52-week low date

2026-06-10

5Y price change

267.77%

5Y return CAGR

29.76%

5Y total return

267.77%

6M price change

-28.6%

6M total return

-28.6%

All-time high

$212.75

All-time high date

2025-12-02

All-time low

$2.64

All-time low date

2011-11-25

Average true range (ATR)

$3.69

Average volume

3.2M

Beta (1Y)

0.98

Beta (2Y)

0.9

Beta (5Y)

0.82

Change from 52-week high

-54.27%

Change from 52-week low

7.65%

Change from all-time high

-54.36%

Change from all-time low

3,577.65%

Change from open

3.38%

Day's gap

-0.88%

Dollar volume

$380.9M

High price

$97.91

Low price

$94.12

Monthly RSI

46.77

Open price

$94.12

Position in 52-week range

83.91%

Premarket change

-0.42%

Premarket close

$94.96

Premarket price

$94.56

Premarket volume

2.2K

Previous close

$94.96

Price vs 150-day SMA

-17.42%

Price vs 20-day SMA

-1.88%

Price vs 200-day SMA

-22.9%

Price vs 50-day SMA

-14.3%

Relative volume

1.24

RSI

38.38

Sharpe ratio

-0.6

Sharpe ratio (3Y)

0.79

Sharpe ratio (5Y)

0.58

Sortino ratio

-0.8

Sortino ratio (3Y)

2.26

Sortino ratio (5Y)

1.41

Volume

3.9M

Weekly RSI

39.48

YTD price change

-44.21%

YTD total return

-44.21%

Metric	Value
Float	216.9M
Float percentage	99.34%
Shares change (QoQ)	0.87%
Shares change (YoY)	18.73%
Shares held by insiders	0.62%
Shares held by institutions	104.58%
Shares outstanding	218.4M
Short % of float	6.36%
Short % of shares	6.32%
Short ratio	6.5 days

Metric

Value

Float

216.9M

Float percentage

99.34%

Shares change (QoQ)

0.87%

Shares change (YoY)

18.73%

Shares held by insiders

0.62%

Shares held by institutions

104.58%

Shares outstanding

218.4M

Short % of float

6.36%

Short % of shares

6.32%

Short ratio

6.5 days

Insmed Incorporated (INSM)

Price

Financial snapshot

Fair-value bridge

Latest news · INSM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All INSM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on INSM

Frequently asked questions